Live vaccines—a short‐cut to cancer viro‐immunotherapy
Abstract Tumour immunotherapies have been a breakthrough in clinical oncology but only a few patients benefit from this progress. Additional interventions that sensitize immunologically cold tumours for the administration of checkpoint modifiers are urgently needed. In this issue of EMBO Molecular M...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Nature
2019-11-01
|
| シリーズ: | EMBO Molecular Medicine |
| オンライン･アクセス: | https://doi.org/10.15252/emmm.201911496 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|